 "Oberoi Realty successfully bids for Thane property; stock hits new high")
Oberoi Realty hit a fresh high of Rs 438, up 8% on BSE in an other wise weak market in intra-day trade, after the company announced that GlaxoSmithKline Pharmaceuticals Limited ('GSK') has selected the real estate company as the successful bidder for its Thane property.
“GlaxoSmithKline Pharmaceuticals Limited ('GSK') has selected Oberoi Realty Limited as the successful bidder for the land admeasuring approximately 60 acres located at Thane, Maharashtra,” Oberoi Realty said in a BSE filing.
The Company's bid for purchase of the said land was for a consideration of Rs 555 crore, it added.
The proposed purchase of land is subject to compliance and adherence with the terms and conditions of the bid, including receipt of all statutory and regulatory approvals from the concerned authorities and signing of definitive documents between the Company and GSK in this regard, Oberoi Realty said.
In past one month, the stock has outperformed the market by gaining 17% against 0.4% decline in the S&P BSE Sensex.
At 10:22 am, the stock was up 4.5% at Rs 425 against 0.92% fall in the benchmark index. A combined 413,248 shares changed hands on the counter on BSE and NSE.
“GlaxoSmithKline Pharmaceuticals Limited ('GSK') has selected Oberoi Realty Limited as the successful bidder for the land admeasuring approximately 60 acres located at Thane, Maharashtra,” Oberoi Realty said in a BSE filing.
The Company's bid for purchase of the said land was for a consideration of Rs 555 crore, it added.
The proposed purchase of land is subject to compliance and adherence with the terms and conditions of the bid, including receipt of all statutory and regulatory approvals from the concerned authorities and signing of definitive documents between the Company and GSK in this regard, Oberoi Realty said.
In past one month, the stock has outperformed the market by gaining 17% against 0.4% decline in the S&P BSE Sensex.
At 10:22 am, the stock was up 4.5% at Rs 425 against 0.92% fall in the benchmark index. A combined 413,248 shares changed hands on the counter on BSE and NSE.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%